Citadel Advisors’s Clorox CLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$148M Sell
1,426,468
-2,816
-0.2% -$319K 0.02% 598
2025
Q4
$144M Buy
1,429,284
+1,403,060
+5,350% +$152M 0.02% 647
2025
Q3
$3.23M Sell
26,224
-477,418
-95% -$59.3M ﹤0.01% 5172
2025
Q2
$60.5M Buy
503,642
+491,768
+4,142% +$65.6M 0.01% 1092
2025
Q1
$1.75M Sell
11,874
-1,018,538
-99% -$156M ﹤0.01% 5792
2024
Q4
$167M Sell
1,030,412
-1,145,835
-53% -$187M 0.03% 477
2024
Q3
$355M Sell
2,176,247
-654,225
-23% -$96.9M 0.07% 203
2024
Q2
$386M Buy
2,830,472
+762,947
+37% +$106M 0.08% 170
2024
Q1
$317M Buy
2,067,525
+1,233,751
+148% +$184M 0.06% 228
2023
Q4
$119M Buy
833,774
+614,656
+281% +$81.9M 0.02% 590
2023
Q3
$28.7M Sell
219,118
-84,921
-28% -$12.9M 0.01% 1538
2023
Q2
$48.4M Buy
304,039
+288,342
+1,837% +$46.5M 0.01% 1083
2023
Q1
$2.48M Sell
15,697
-86,253
-85% -$12.9M ﹤0.01% 4972
2022
Q4
$14.3M Buy
101,950
+14,100
+16% +$2M ﹤0.01% 2357
2022
Q3
$11.3M Sell
87,850
-351,732
-80% -$50.8M ﹤0.01% 2599
2022
Q2
$62M Buy
439,582
+333,429
+314% +$47.6M 0.02% 862
2022
Q1
$14.8M Sell
106,153
-165,337
-61% -$25.3M ﹤0.01% 2396
2021
Q4
$47.3M Buy
271,490
+45,080
+20% +$7.51M 0.01% 1213
2021
Q3
$37.5M Buy
226,410
+166,241
+276% +$28.6M 0.01% 1346
2021
Q2
$10.8M Sell
60,169
-524,070
-90% -$95.7M ﹤0.01% 2959
2021
Q1
$113M Buy
584,239
+273,511
+88% +$52.6M 0.03% 530
2020
Q4
$62.7M Sell
310,728
-54,574
-15% -$11.3M 0.02% 800
2020
Q3
$76.8M Buy
365,302
+62,785
+21% +$14M 0.02% 606
2020
Q2
$66.4M Buy
302,517
+148,863
+97% +$29.7M 0.02% 621
2020
Q1
$26.6M Buy
153,654
+52,308
+52% +$8.64M 0.01% 1018
2019
Q4
$15.6M Sell
101,346
-83,162
-45% -$12.4M 0.01% 1726
2019
Q3
$28M Sell
184,508
-189,187
-51% -$29.9M 0.01% 1183
2019
Q2
$57.2M Buy
373,695
+300,089
+408% +$45.8M 0.03% 657
2019
Q1
$11.8M Sell
73,606
-99,302
-57% -$15.4M 0.01% 1872
2018
Q4
$26.7M Buy
172,908
+163,518
+1,741% +$25.5M 0.01% 1009
2018
Q3
$1.41M Buy
+9,390
New +$1.33M ﹤0.01% 4965
2018
Q1
Sell
-4,175
Closed -$561K 8316
2017
Q4
$621K Sell
4,175
-56,967
-93% -$7.75M ﹤0.01% 5340
2017
Q3
$8.06M Buy
61,142
+53,719
+724% +$7.22M 0.01% 1813
2017
Q2
$989K Sell
7,423
-211,272
-97% -$28.5M ﹤0.01% 4089
2017
Q1
$29.5M Buy
218,695
+3,914
+2% +$507K 0.03% 731
2016
Q4
$25.8M Buy
214,781
+159,655
+290% +$18.8M 0.03% 701
2016
Q3
$6.9M Buy
+55,126
New +$7.22M 0.01% 1681
2016
Q2
Sell
-144,002
Closed -$18.7M 6864
2016
Q1
$18.2M Buy
144,002
+137,494
+2,113% +$17.5M 0.02% 809
2015
Q4
$825K Sell
6,508
-1,458
-18% -$181K ﹤0.01% 3820
2015
Q3
$920K Buy
+7,966
New +$894K ﹤0.01% 3927
2015
Q2
Sell
-220,872
Closed -$23.8M 8760
2015
Q1
$24.4M Buy
220,872
+150,121
+212% +$16.3M 0.02% 869
2014
Q4
$7.37M Buy
70,751
+58,895
+497% +$5.89M 0.01% 1637
2014
Q3
$1.14M Sell
11,856
-30,547
-72% -$2.76M ﹤0.01% 3547
2014
Q2
$3.88M Buy
42,403
+28,261
+200% +$2.53M ﹤0.01% 2068
2014
Q1
$1.25M Sell
14,142
-5,969
-30% -$524K ﹤0.01% 3160
2013
Q4
$1.86M Buy
20,111
+20,108
+670,267% +$1.81M ﹤0.01% 2614
2013
Q3
$0 Sell
3
-62,836
-100% -$5.3M ﹤0.01% 6741
2013
Q2
$5.22M Buy
+62,839
New +$5.41M 0.01% 1535

Other funds holding CLX

Citadel Advisors's CLX Position: Q1 2026 in Review

Citadel Advisors reduced its Clorox (CLX) stake by 0.2% in Q1 2026, selling an estimated $319K and leaving 1,426,468 shares worth $148M. The position accounts for 0.02% of the portfolio, ranked #598.

Citadel Advisors first reported a position in CLX in Q2 2013 and has held it in 48 quarters since. The position peaked at $386M in Q2 2024. 1,080 funds tracked by Wall St. Rank hold CLX as of Q1 2026.

  • Citadel Advisors held 1,426,468 shares of Clorox worth $148M as of Q1 2026.
  • Citadel Advisors sold 2,816 Clorox shares in Q1 2026, an estimated $319K.
  • Clorox made up 0.02% of Citadel Advisors's portfolio in Q1 2026, its #598 holding.
  • Citadel Advisors first reported a position in Clorox in Q2 2013 and has held it in 48 quarters since.
  • Citadel Advisors's Clorox position peaked at $386M in Q2 2024.
  • 1,080 funds tracked by Wall St. Rank held Clorox as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.